{
    "clinical_study": {
        "@rank": "25008", 
        "arm_group": [
            {
                "arm_group_label": "Cross Linking Group (CxL group)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients that received CXL"
            }, 
            {
                "arm_group_label": "Cross Linking with topo-guided PRK (tCxL)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients that received tCxL"
            }
        ], 
        "brief_summary": {
            "textblock": "Study Hypothesis: Former investigators indicated that keratoconus has a negative impact on\n      vision-specific quality of life. This study attempts to confirm this statement and assess\n      whether cross-linking and cross-linking combined with photorefractive keratectomy improve\n      vision-specific quality of life, in a sample of keratoconus patients with 3-years follow-up."
        }, 
        "brief_title": "Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Keratoconus", 
        "condition_browse": {
            "mesh_term": "Keratoconus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  be diagnosed and classified as stage 1 keratoconus according to the Amsler-Krumeich\n             classification system for keratoconus\n\n          -  present progressive keratoconus in consecutive corneal topographies, and/or changes\n             in their refractive power.\n\n        Progressive keratoconus was defined when any of the following criteria was met for a\n        period of 24 months:\n\n          -  an increase of 1.00 diopter (D) or more in the steepest keratometry measurement\n\n          -  an increase of 1.00 D or more in manifest cylinder\n\n          -  an increase of 0.50 D or more in manifest refraction spherical equivalent.\n\n        Exclusion Criteria:\n\n          -  glaucoma\n\n          -  suspicion for glaucoma\n\n          -  IOP-lowering medications\n\n          -  central corneal thickness (CCT) less than 400\u03bcm\n\n          -  K-readings more than 60D\n\n          -  history of herpetic keratitis\n\n          -  corneal scarring\n\n          -  severe eye dryness\n\n          -  pregnancy or nursing\n\n          -  current corneal infection\n\n          -  or underlying autoimmune disease KG members were further sub-divided into CxL and\n             tCxL groups, according to their eligibility for treatment with CxL or CxL with tPRK.\n             In order to be eligible for tCxL, group participants should, additionally, have CCT\n             above 450\u03bcm."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01845714", 
            "org_study_id": "EIT-KC-VSQOL3"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cross Linking Group (CxL group)", 
                "intervention_name": "Corneal Cross Linking", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Cross Linking with topo-guided PRK (tCxL)", 
                "intervention_name": "Corneal Cross Linking combined with topoguided PRK", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Keratoconus", 
            "Corneal cross Linking", 
            "Topo guided PRK", 
            "Quality of Life"
        ], 
        "lastchanged_date": "May 1, 2013", 
        "number_of_arms": "2", 
        "official_title": "Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: Ministry of Health and Welfare"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Vision Specific quality of Life (VS-QoL)", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01845714"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Democritus University of Thrace", 
            "investigator_full_name": "Georgios Labiris", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Democritus University of Thrace", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Democritus University of Thrace", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2009", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}